With their high tolerability and minimal side effects, peptides are transforming the way we approach chronic disease management, providing hope for patients who have long struggled with persistent symptoms and limited treatment options
The incidence of this behaviour is increasing ..This appears to be due to a cost saving exercise and largely happens without any prior consultation with individual patients to discuss their needs
Shmerling, MD Senior Faculty Editor, Harvard Health Publishing
We measure, we understand, and we correct the underlying chemistry
BPC-157 may cause temporary injection site reactions in fewer than 5% of patients
for the broader peptide-blend decision framework, see When Do You Actually Need a Peptide Blend